文献速递白血病

Ars2缺失通过调控miR-6734-3p/p27轴抑制急性髓系白血病细胞增殖与白血病发生

Depletion of Ars2 inhibits cell proliferation and leukemogenesis in acute myeloid leukemia by modulating the miR-6734-3p/p27 axis.
PubMed 文献 · Leukemia · 2018-12-05

研究显示Ars2在急性髓系白血病(AML)细胞系及患者骨髓样本中表达升高,且与较差的总生存相关。过表达Ars2促进AML细胞增殖和集落形成,而缺失Ars2则抑制增殖、阻滞细胞周期于G1期,并在小鼠体内减少白血病负荷、延长生存。机制上,Ars2缺失减弱其与核帽结合复合体(CBC)的相互作用,降低miR-6734-3p水平,上调p27。

要点

  • Ars2在AML细胞系和患者骨髓中表达升高,与较差总生存相关。
  • 缺失Ars2通过降低miR-6734-3p上调p27,诱导G1期细胞周期阻滞。
  • 体内实验显示缺失Ars2减少白血病负荷并延长荷瘤小鼠生存。

核心结论

  • Ars2可能在细胞增殖和白血病发生的调控中起关键作用,并可能成为治疗AML的重要治疗靶点。

研究设计与样本

  • 研究采用AML细胞系、AML患者骨髓样本及白血病荷瘤小鼠模型,进行体外和体内功能与机制研究。

主要发现

  • Ars2在AML细胞系和AML患者骨髓样本中表达升高,并与较差的总生存相关。
  • 过表达Ars2促进AML细胞增殖和集落形成,而缺失Ars2抑制细胞增殖和集落形成。
  • 缺失Ars2抑制Ars2与CBC的相互作用,导致miRNA加工改变,降低miR-6734-3p水平,上调p27,引起G1期细胞周期阻滞。
  • 体内研究显示,缺失Ars2显著减少白血病细胞负荷并延长荷瘤小鼠的生存时间。

关键数值与推荐

  • Ars2在AML细胞系和患者骨髓样本中表达升高,且与较差的总生存相关。
  • 过表达Ars2促进AML细胞增殖和集落形成,缺失Ars2抑制增殖和集落形成。
  • 缺失Ars2降低miR-6734-3p水平,上调p27,导致G1期细胞周期阻滞。
  • 体内研究显示缺失Ars2显著减少白血病细胞负荷并延长荷瘤小鼠生存时间。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ars2 is a component of the nuclear cap-binding complex (CBC) that contributes to microRNA biogenesis and is required for cellular proliferation. Little is known regarding the functional role of Ars2 in cell proliferation and leukemogenesis of acute myeloid leukemia. Here, we show that the elevated expression of Ars2 was observed in acute myeloid leukemia (AML) cell lines and bone marrow samples from AML patients and was correlated with poorer overall survival. Overexpression of Ars2 promoted cell proliferation and colony formation in AML cells, whereas depletion of Ars2 inhibited cell proliferation and colony formation. Mechanistic studies reveal that depletion of Ars2 suppressed the interaction of Ars2 with CBC and led to alterations in miRNA processing. Furthermore, Ars2 depletion reduced the levels of miR-6734-3p, resulting in upregulation of p27 and culminating in cell cycle arrest at the G1 phase. In vivo studies indicate that depletion of Ars2 significantly reduced leukemic cell burden and prolonged the survival time of the leukemia-bearing mice. These findings indicate that Ars2 may not only play a crucial role in the regulation of cell proliferation and leukemogenesis, but could also be identified as a critical therapeutic target for treatment of AML.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Hu X, Xu S, Chen Y, et al. Depletion of Ars2 inhibits cell proliferation and leukemogenesis in acute myeloid leukemia by modulating the miR-6734-3p/p27 axis. Leukemia. 2018. PMID: 30518811. doi:10.1038/s41375-018-0301-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。